Patents by Inventor EARL KIM

EARL KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240254227
    Abstract: The present disclosure is generally directed to antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a CD300LB polypeptide, e.g., a mammalian CD300LB or human CD300LB, and use of such compositions in preventing, reducing risk, or treating a disease or disorder an individual in need thereof.
    Type: Application
    Filed: April 17, 2024
    Publication date: August 1, 2024
    Applicant: Alector LLC
    Inventors: Sarah Emily Headland, Ilaria Tassi, Chenyu A. Lee, Earl Kim, Adiljan Ibrahim, Marina Roell, Angie Grace Yee
  • Publication number: 20190016812
    Abstract: Provided are novel anti-TNFSF9 antibodies and antibody drug conjugates, and methods of using such anti-TNFSF9 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 17, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JEFFREY BERNSTEIN, DAVID COELHO, LAURA SAUNDERS, AMY LAYSANG, SAMUEL A, WILLIAMS, DAVID LIU, EARL KIM, ROBERT A. STULL
  • Publication number: 20190000969
    Abstract: Provided are novel anti-UPK1B antibodies and antibody drug conjugates, and methods of using such anti-UPK1B antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 3, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: KRISTEN MCKNIGHT, SARAH FONG, SAMUEL A. WILLIAMS, ZHAO HUANG, EARL KIM, ROBERT A. STULL, DAVID COELHO, WADE C. ANDERSON, MARIANNE SANTAGUIDA
  • Patent number: D863359
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: October 15, 2019
    Inventor: Earl Kim